These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30018047)

  • 1. Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development.
    Juneja M; Burns J; Saporta MA; Timmerman V
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):58-67. PubMed ID: 30018047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease.
    Young P; Suter U
    Brain Res Brain Res Rev; 2001 Oct; 36(2-3):213-21. PubMed ID: 11690618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication.
    Liu X; Ishikawa KI; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Jun; 77():103401. PubMed ID: 38537501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
    Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population.
    Gess B; Schirmacher A; Boentert M; Young P
    Neuromuscul Disord; 2013 Aug; 23(8):647-51. PubMed ID: 23743332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.
    Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T
    Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
    Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
    Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
    Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causes of Charcot-Marie-Tooth disease.
    Young P; Suter U
    Cell Mol Life Sci; 2003 Dec; 60(12):2547-60. PubMed ID: 14685682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature.
    Kitani-Morii F; Imamura K; Kondo T; Ohara R; Enami T; Shibukawa R; Yamamoto T; Sekiguchi K; Toguchida J; Mizuno T; Nakagawa M; Inoue H
    Neuroreport; 2017 Sep; 28(13):814-821. PubMed ID: 28704293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.
    Niemann A; Berger P; Suter U
    Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
    Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
    Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
    Stavrou M; Sargiannidou I; Georgiou E; Kagiava A; Kleopa KA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.
    Houlden H; Reilly MM
    Neuromolecular Med; 2006; 8(1-2):43-62. PubMed ID: 16775366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease.
    Meggouh F; de Visser M; Arts WF; De Coo RI; van Schaik IN; Baas F
    Ann Neurol; 2005 Apr; 57(4):589-91. PubMed ID: 15786462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP.
    Jouaud M; Mathis S; Richard L; Lia AS; Magy L; Vallat JM
    J Neurol Sci; 2019 Mar; 398():79-90. PubMed ID: 30685714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PMP22 mutation of an infant-onset Charcot-Marie-Tooth disease family].
    Xing JW; Liu YH; Shamsi BH; Liu XH; Tan L; Xu M
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Oct; 13(10):799-803. PubMed ID: 22000434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcot-Marie-Tooth disease: an update.
    Shy ME
    Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.